Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-250651
Filing Date
2024-11-04
Accepted
2024-11-04 16:31:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d809645ds3.htm S-3 301102
2 EX-5.1 d809645dex51.htm EX-5.1 9369
3 EX-23.1 d809645dex231.htm EX-23.1 2206
4 EX-FILING FEES d809645dexfilingfees.htm EX-FILING FEES 18877
5 GRAPHIC g809645dsp001.jpg GRAPHIC 4353
6 GRAPHIC g809645g44w42.jpg GRAPHIC 47749
7 GRAPHIC g809645g77v37.jpg GRAPHIC 29529
  Complete submission text file 0001193125-24-250651.txt   438473
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282984 | Film No.: 241424079
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)